A two-day immersive course crafted to equip participants with an in-depth understanding of remote audit methodologies. 2nd - 3rd June.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationOn World Standards Day, 14th October 2025, the MHRA commemorates a century of ensuring the safety, efficacy, and consistency of medicines and vaccines through biological standards.
The MHRA's Interim Executive Director of Science and Research discusses the approval of gepotidacin, the UK's first new antibiotic for urinary tract infections in nearly 30 years, and the broader challenge of combating antibiotic resistance.
The European Medicines Agency (EMA) has released the 22nd edition of its quarterly newsletter, providing updates on veterinary medicines regulation as of October 2025.
The MHRA explores the unique challenges of supplying medicines to remote locations via air and sea, emphasising compliance with Good Distribution Practice (GDP).
The European Medicines Agency (EMA) Management Board convened on 2nd October 2025, reviewing mid-year performance and endorsing strategic initiatives.
The European Medicines Agency (EMA) has released a draft reflection paper inviting public consultation on integrating patient experience data into the regulatory process.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) convened from 29th September to 2nd October 2025, addressing various aspects of medicine safety.
The FDA has finalised guidance on employing alternative tools to evaluate drug manufacturing facilities in pending applications.
The MHRA invites medical students and foundation doctors to explore how genetics can enhance prescribing safety and patient outcomes in the UK.
The MHRA has released updated guidance for conducting clinical trials that include in vitro diagnostic (IVD) devices.